Amit Momaya
Sports Medicine · Birmingham, ALNPI 1508156894
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (51.0%), travel and lodging and education — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Linvatec Corporation at 55.9% of the total. Reporting peaked in 2024 at $30,621 and has fallen 50.7% since, to $15,083 in 2025. Among sports medicine clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 144 payments — averaging $533.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Linvatec Corporation$43K
- Miach Orthopaedics, Inc.$13K
- Prime Surgical, LLC$9K
- Arthrex$6K
- Fidia Pharma USA Inc.$3K
- Synthes GmbH$2K
- plus $2K from 15 others
Across 4 payments — averaging $20,342 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Linvatec Corporation$81K
What the payments were for
- Consulting fees$39,25051%
- Speaking & faculty fees$7,2509%
- Travel & lodging$17,71323%
- Food & beverage$3,8685%
- Education$8,80711%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Linvatec Corporation | 42 | $42,988 |
| Miach Orthopaedics, Inc. | 4 | $12,750 |
| Prime Surgical, LLC | 27 | $9,044 |
| Arthrex | 23 | $5,808 |
| Fidia Pharma USA Inc. | 4 | $2,584 |
| Synthes GmbH | 3 | $2,096 |
| Smith+Nephew | 16 | $552 |
| Stryker | 4 | $201 |
| Abanza Inc. | 2 | $188 |
| Bioventus LLC | 5 | $177 |
| Bodycad USA Corp | 1 | $112 |
| Exactech, Inc. | 1 | $97 |
| Zimmer Biomet | 2 | $90 |
| Johnson & Johnson(2 entities) | 2 | $55 |
| Pacira Therapeutics, Inc. | 2 | $36 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| ERMI LLC | 1 | $22 |
| Orthofix Medical, Inc. | 1 | $20 |
| Illuminoss Medical, Inc. | 1 | $16 |
| Next Science LLC | 1 | $15 |
| Innovation Technologies Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$76,888 in reported general payments places this provider in the 95th percentile of 108 sports medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methocarbamol | 25 | $128 |
| Ondansetron OdtOndansetron | 22 | $113 |
| Oxycodone Hcl | 24 | $95 |
| Gabapentin | 22 | $66 |
| Meloxicam | 17 | $45 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Birmingham
- Edward CainBirmingham$12.7M
- Mark RogersBirmingham$94K
- Christoper GarrettBirmingham$58K
- Reaves CrabtreeBirmingham$47K
- David AdkisonBirmingham$46K
- Amir ShahienBirmingham$45K
- Christopher CarterBirmingham$42K
- Christian MerrillBirmingham$40K
- Thomas EvelyBirmingham$34K
- Aaron JoinerBirmingham$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.